In Reply Decision making on the use of oral anticoagulant treatment in patients with atrial fibrillation is often uncomplicated due to the positive risk-benefit ratio, ie, balancing risk of bleeding against benefit from thromboprophylaxis. Observational data on patients with atrial fibrillation sustaining an intracranial hemorrhage are increasing, recognizing the treatment conundrum of resuming oral anticoagulant treatment since the risk-benefit ratio of treatment is shifted substantially.

中文翻译：

---

并非均等地产生各种类型的出血性中风-答复

在房颤患者中使用口服抗凝治疗的决策通常并不复杂，因为其风险收益比为正，即在出血风险与预防血栓风险之间取得平衡。关于房颤持续颅内出血的患者的观察数据正在增加，这认识到恢复口服抗凝治疗的治疗难题，因为治疗的风险收益率发生了很大的变化。